Rocket Pharmaceuticals (RCKT) Change in Account Payables (2014 - 2017)
Rocket Pharmaceuticals (RCKT) posted Change in Account Payables of $68000.0 for Q4 2017, up 353.33% sequentially from $15000.0 in Q3 2017, and up 136.76% YoY from $28721.5 in Q4 2016.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Change in Account Payables (2014 - 2017) Analysis & Trends
Rocket Pharmaceuticals has reported Change in Account Payables for 4 years, with the latest figure at $68000.0 in Q4 2017.
- Quarterly Change in Account Payables rose 136.76% year-over-year to $68000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was -$1.1 million (down 2682.93% YoY) and the FY2017 annual result came in at -$1.1 million, down 2682.93% from the prior year.
- Change in Account Payables improved to $68000.0 in Q4 2017 per RCKT's latest filing, from $15000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $896000.0 in Q3 2015 and troughed at -$1.5 million in Q2 2017.
- A 4-year average of $13875.0 and a median of $41500.0 in 2017 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 527.78% in 2015, down 393.37% in 2015.
- Over 4 years, Change in Account Payables stood at $98000.0 in 2014, then tumbled by 177.55% to -$76000.0 in 2015, then tumbled by 143.42% to -$185000.0 in 2016, then soared by 136.76% to $68000.0 in 2017.
- According to Business Quant data, Change in Account Payables over the past three periods registered $68000.0, $15000.0, and -$1.5 million for Q4 2017, Q3 2017, and Q2 2017 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Rocket Pharmaceuticals | 437.27 Mn | 437.27 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 68,000.00 |
| Sep 30, 2017 | 15,000.00 |
| Jun 30, 2017 | -1.53 Mn |
| Mar 31, 2017 | 310,000.00 |
| Dec 31, 2016 | -185,000.00 |
| Sep 30, 2016 | 856,000.00 |
| Jun 30, 2016 | -455,000.00 |
| Mar 31, 2016 | -257,000.00 |
| Dec 31, 2015 | -76,000.00 |
| Sep 30, 2015 | 896,000.00 |
| Jun 30, 2015 | -487,000.00 |
| Mar 31, 2015 | 154,000.00 |
| Dec 31, 2014 | 98,000.00 |
| Sep 30, 2014 | 689,000.00 |
| Jun 30, 2014 | 166,000.00 |
| Mar 31, 2014 | -36,000.00 |